Pear Sign a Multiple Agreements to Expands its Prescription Digital Therapeutic Platform

 Pear Sign a Multiple Agreements to Expands its Prescription Digital Therapeutic Platform

Pear Sign a Multiple Agreements to Expands its Prescription Digital Therapeutic Platform

Shots:

  • Pear collaborates with Empatica, etectRx and KeyWise to bolster its PDT platform with digital biomarkers, machine learning algorithms, sensor-based technologies, and digital therapeutics
  • The new technologies complement its voice-based biomarkers previously licensed from Winterlight. The licensed technologies will facilitate the building of products for patients’ physiologic sensing
  • Pear’s physiologic sensing portfolio allows personalizing products in real-time and pharmaceutical dosing, thus providing an opportunity for enhanced patient outcomes across a wide range of disease states

Click here to­ read full press release/ article | Ref: Pear Therapeutics | Image: PMLive

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post